ADURO BIOTECH INC's ticker is ADRO and the CUSIP is 00739L101. A total of 87 filers reported holding ADURO BIOTECH INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,086,000 | -20.4% | 470,227 | -5.5% | 0.07% | -34.5% |
| Q1 2020 | $1,364,000 | +262.8% | 497,857 | +56.2% | 0.11% | +242.4% |
| Q4 2019 | $376,000 | +375.9% | 318,734 | +326.1% | 0.03% | +371.4% |
| Q3 2019 | $79,000 | -34.2% | 74,796 | -4.1% | 0.01% | -36.4% |
| Q2 2019 | $120,000 | -60.5% | 77,962 | +2.1% | 0.01% | -62.1% |
| Q1 2019 | $304,000 | +125.2% | 76,330 | +49.1% | 0.03% | +45.0% |
| Q4 2018 | $135,000 | – | 51,207 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVARD MANAGEMENT CO INC | 640,595 | $4,708,000 | 1.20% |
| BVF INC/IL | 287,776 | $2,115,000 | 0.19% |
| ORACLE INVESTMENT MANAGEMENT INC | 111,542 | $820,000 | 0.18% |
| Sofinnova Investments, Inc. | 189,579 | $1,393,000 | 0.12% |
| CENTAURUS FINANCIAL, INC. | 85 | $624,000 | 0.11% |
| Artal Group S.A. | 550,000 | $4,043,000 | 0.10% |
| Vident Investment Advisory, LLC | 305,311 | $2,244,000 | 0.09% |
| Virtus ETF Advisers LLC | 61,463 | $452,000 | 0.05% |
| Foundry Partners, LLC | 106,907 | $786,000 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 239,301 | $1,759,000 | 0.02% |